Alexander Kozak - D Pharm Co-Founder, CEO and Pres

DPRM -- Israel Stock  

ILS 430.00  0.60  0.14%

Dr. Alexander Kozak was appointed Director at D Pharm Ltd effective November 1, 2015. His work experience at the Company includes the following roles Chief Executive Officer, Chief Executive Officer and Director and as President, Chief Executive Officer and Founder . He serves on the Board of Directors of several Israeli startup companies and is a member of the Israeli governmental Committee for Incubator Companies. Dr. Kozak is a member of the Society for Neurosciences, the Society for Neurochemistry, LES and the New York Academy of Sciences
Age: 59  CEO Since 2015  Ph.D    
972 8 938 5100
Kozak holds a Doctorate of Medicine degree in Neurobiology from The Weizmann Institute of Science.

Management Efficiency

The company has return on total asset (ROA) of (42.09) % which means that it has lost $42.09 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (400.0) % meaning that it generated substantial loss on money invested by shareholders.
The company has accumulated 317K in total debt with debt to equity ratio (D/E) of 45.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. D Pharm LTD has Current Ratio of 1.51 which is within standard range for the sector.

Similar Executives

Found 6 records

CEO Since

Gil EfronKitov Pharma Ltd
Itzhak IsraelKitov Pharma Ltd
Menachem CohenMedivie Therapeutic Ltd
Yuval BernshteinSolegreen Ltd
Tom ShafranSolegreen Ltd
Itai HechtMedivie Therapeutic Ltd

Entity Summary

D-Pharm LTD., a drug-development company, focuses on the development of drugs for the treatment of central nervous system conditions. D-Pharm LTD. was founded in 1993 and is based in Rehovot, Israel. D Pharm operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.D Pharm LTD (DPRM) is traded on Tel Aviv Stock Exchange in Israel and employs 11 people.

D Pharm LTD Leadership Team

Emanuel Kahane, IR Contact Officer
Tamar Kfir, Director
Ofir Shachaf, Director
Irit Kaufman, Independent Director
David Grossman, Chairman of the Board
Itschak Shrem, Chairman of the Board
Aharon Schwartz, Executive Chairman of the Board
Golan Bitton, CEO, Director
Ronen Rosenbloom, Director
Nir Zvi, Director
Ofra Yamin, VP of Fin. and HR
Yaron Meyer, General Counsel, Secretary
Assaf Segal, Director
Ofer Gonen, Director
Joshua Levine, Director
Anat Benish, External Director
Sagi Tamir, External Director
Yossi Hatan, Vice President - Finance
Gilad Rosenberg, Vice President Clinical Development
Sigal Gefen, External Director
Eli Cohen, Director
Alexander Kozak, Co-Founder, CEO and Pres
Zohara Ran, Independent Director

Stock Performance Indicators

Current Sentiment - DPRM

D Pharm LTD Investor Sentiment

Macroaxis portfolio users are insensible in their opinion about investing in D Pharm LTD. What is your opinion about investing in D Pharm LTD? Are you bullish or bearish?
50% Bullish
50% Bearish

D Pharm Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for D Pharm and Kitov Pharma. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.